Clinical Research

Achalasia is a rare disease, affecting 1 in 100,000 people, characterized by a loss of nerve cells in the esophageal wall and manifested as chest pain during eating, weight loss, and regurgitation of…

New York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. has published results from the long-term, randomized, active control Phase 3 study of Zerenex (ferric citrate), their investigational…

A study has documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms; weaknesses in the body's largest artery that can…

Each year, roughly 250,000 people in the United States require hospital care for Clostridium difficile (C. difficile) infection and at least 14,000 people die from it, according to the U.S. Centers…

Doctors at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix report  in Lancet Oncology that a new treatment for ovarian cancer can improve response…

Bellerophon Therapeutics has completed enrollment of its 80-patient Phase 2 clinical trial of INOpulse for the treatment of pulmonary arterial hypertension (PAH). PAH is a life-threatening,…

Amgen announced that it will collaborate with the National Cancer Institute and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a clinical trial program that will use…

In humans, no therapy for  amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease,  has ever been discovered that could extend lifespan more than a few additional months. ALS was…

Individuals who are hospitalized for the skin conditions of Stevens-Johnson syndrome and toxic epidermal necrolysis appear to have a high risk of recurrence, according to a new study. Stevens-Johnson…

Wine was once okay for pregnant women in moderation, then all alcohol was bad, then wine was good again because of the miracle product du jour,  resveratrol , but now it may be bad again. A new…